Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Clinical evidence RECONNECT trials: The FDA approval was based on two Phase 3 trials involving over 1,200 premenopausal women with HSDD: Significant increases in Female Sexual Function Index-desire domain scores Reduced distress related to low sexual desire Benefits maintained through 52-week open-label extension Rapid improvement when placebo patients switched to active treatment Earlier research: A 2006 study in premenopausal women with sexual arousal disorder found significantly more women reported moderate or high sexual desire after PT-141 compared to placebo (p=0.0114)
Liraglutide has a longer track record and more long-term data on outcomes, though it requires a daily injection
If you are comfortable at a lower dose of Wegovy or Mounjaro for weight loss, you can stick to that rather than titrating up to the maximum maintenance dose
When you compare retatrutide peptide, look for clear lab proof and honest labeling, and walk away from anything that hides its data
3,4 They also prevent oxidative stress, which occurs when there is an imbalance between free radicals and antioxidants, leading to cell and tissue damage
US$ 25.90
US$ 20.14
US$ 29.87
US$ 20.63
US$ 25.36
US$ 21.77
US$ 28.98
US$ 21.89
